Search Results

BREAKING NEWS … CANADIANS ONE STEP CLOSER TO LUXTURNA GENE THERAPY ACCESS

Fighting Blindness Canada is excited to announce that Canadians are one step closer to being able to access voretigene neparvovec (Luxturna), the first gene therapy for an inherited retinal disease. As of...

DEVELOPING A STEM CELL THERAPY TO RESTORE SIGHT

Fighting Blindness Canada is pleased to announce that the team of Dr. David Gamm (University of Wisconsin) and Dr. William Beltran (University of Pennsylvania) have been awarded $725,000 to continue their ground-breaking...

HEALTH INFORMATION LINE

Getting diagnosed with an eye disease and navigating tests, appointments, and treatments can be confusing and complicated. Fighting Blindness Canada’s (FBC) Health Information Line is here to answer your eye health-related questions....

CORPORATE PARTNERS

Fighting Blindness Canada’s (FBC) corporate partners and sponsors help us fund innovative treatments and cures for 1.2 million Canadians living with vision loss, as well as national education programs bringing awareness to...

RESTORE VISION 20/20 RESEARCH AWARDS: DEVELOPING TREATMENTS TO RESTORE SIGHT

In 2018 Fighting Blindness Canada (FBC) announced the first Restore Vision 20/20 research awards which support world-class research teams to develop therapeutic approaches for late-stage retinal degeneration, specifically retinitis pigmentosa (RP). Through...

FBC-FUNDED RESEARCHER STUDIES PHOTORECEPTOR CELL METABOLISM IN RP

Fighting Blindness Canada (FBC) is pleased to be supporting Dr. Peter Campochiaro’s (Wilmer Eye Institute, John Hopkins University) research into retinitis pigmentosa (RP). Dr. Campochiaro is a world-renowned clinician-scientist whose research program...